Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. MSN/2026/002 Tier 2 – Medium impact Date of issue: 15 January 2026 Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets were discontinued on 5th January 2026. Various strengths (0.7mg/0.18mg, 1.4mg/0.36mg, 5.7mg/1.4mg, 8.6mg/2.1mg, and 11.4mg/2.9mg) of [...]

The post Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2025/26 Pharmacy Quality Scheme (PQS) declaration so pharmacy owners can view these ahead of making their declaration when the declaration window opens. The questions are available on the NHSBSA PQS hub page; scroll down to the ‘PQS 2025/26’ section where [...]

The post PQS declaration questions published appeared first on Community Pharmacy England.

Alongside critical work making the financial case for the sector, Community Pharmacy England will be working with Pharmacist Support in 2026 to help support the wellbeing of pharmacists and their teams. The continuing fragility of pharmacy finances, alongside high workloads, stress, ongoing uncertainty and rising reports of patient abuse across England, take a real toll [...]

The post Supporting you in 2026: Our work with Pharmacist Support appeared first on Community Pharmacy England.

Pharmacy teams should be aware that all strengths of Subutex® and Suboxone® tablets have been discontinued. The manufacturer, Indivior, is no longer supplying these products in the UK therefore, they are no longer available for community pharmacies to order. Please note that if a prescriber has issued a branded prescription for any strength of Subutex®, [...]

The post Discontinuation of Subutex® and Suboxone® tablets appeared first on Community Pharmacy England.

This article tackles some of the misconceptions around rejecting Pharmacy First referrals and aims to bust myths to increase understanding of the service. We have previously published a series of articles on myth busting covering a variety of aspects of Pharmacy First. All of these myths can be viewed on our Pharmacy First service – [...]

The post Pharmacy First myth busting: To reject or not to reject? appeared first on Community Pharmacy England.